SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092817
Filing Date
2020-08-10
Accepted
2020-08-10 17:00:42
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ntrp-20200630x10q.htm   iXBRL 10-Q 1314636
2 EXHIBIT 31.1 ntrp-20200630xex31d1.htm EX-31.1 11140
3 EXHIBIT 31.2 ntrp-20200630xex31d2.htm EX-31.2 10970
4 EXHIBIT 32.1 ntrp-20200630xex32d1.htm EX-32.1 5650
5 EXHIBIT 32.2 ntrp-20200630xex32d2.htm EX-32.2 5005
11 GRAPHIC ntrp-20200630x10q001.jpg GRAPHIC 7510
  Complete submission text file 0001104659-20-092817.txt   4438051

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20200630.xsd EX-101.SCH 44062
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntrp-20200630_cal.xml EX-101.CAL 22060
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntrp-20200630_def.xml EX-101.DEF 162915
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20200630_lab.xml EX-101.LAB 322335
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20200630_pre.xml EX-101.PRE 283213
12 EXTRACTED XBRL INSTANCE DOCUMENT ntrp-20200630x10q_htm.xml XML 492194
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38045 | Film No.: 201090158
SIC: 2834 Pharmaceutical Preparations